Peter Vavassis

1.6k total citations
21 papers, 170 citations indexed

About

Peter Vavassis is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Cancer Research. According to data from OpenAlex, Peter Vavassis has authored 21 papers receiving a total of 170 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 10 papers in Radiation and 7 papers in Cancer Research. Recurrent topics in Peter Vavassis's work include Prostate Cancer Treatment and Research (11 papers), Advanced Radiotherapy Techniques (10 papers) and Prostate Cancer Diagnosis and Treatment (8 papers). Peter Vavassis is often cited by papers focused on Prostate Cancer Treatment and Research (11 papers), Advanced Radiotherapy Techniques (10 papers) and Prostate Cancer Diagnosis and Treatment (8 papers). Peter Vavassis collaborates with scholars based in Canada, Belgium and Hungary. Peter Vavassis's co-authors include Michael Yassa, David H. Nguyen, Michel Gélinas, Phuc Félix Nguyen‐Tan, Rédouane Bettahar, Boris Bahoric, Nathalie Carrier, Robert Archambault, F. Vincent and Abdenour Nabid and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Peter Vavassis

18 papers receiving 163 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Vavassis Canada 7 79 76 63 58 27 21 170
O. Hernando Spain 8 63 0.8× 58 0.8× 42 0.7× 53 0.9× 17 0.6× 36 196
Mariacarla Valli Switzerland 10 85 1.1× 68 0.9× 71 1.1× 60 1.0× 23 0.9× 23 196
Fabio Arcidiacono Italy 7 114 1.4× 71 0.9× 29 0.5× 55 0.9× 15 0.6× 26 199
Davide Giovanni Bosetti Switzerland 10 134 1.7× 81 1.1× 63 1.0× 93 1.6× 22 0.8× 27 211
Feisal Bunkheila Italy 7 115 1.5× 73 1.0× 23 0.4× 116 2.0× 60 2.2× 14 256
Mark Churn United Kingdom 5 30 0.4× 62 0.8× 126 2.0× 62 1.1× 38 1.4× 9 189
S. Voruganti Canada 5 88 1.1× 80 1.1× 55 0.9× 63 1.1× 30 1.1× 10 192
Archi Agarwal India 6 198 2.5× 98 1.3× 14 0.2× 41 0.7× 8 0.3× 15 260
K. Peignaux-Casasnovas France 8 88 1.1× 94 1.2× 42 0.7× 45 0.8× 15 0.6× 20 158
Mukesh B. Mukesh United Kingdom 5 42 0.5× 124 1.6× 197 3.1× 92 1.6× 64 2.4× 6 249

Countries citing papers authored by Peter Vavassis

Since Specialization
Citations

This map shows the geographic impact of Peter Vavassis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Vavassis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Vavassis more than expected).

Fields of papers citing papers by Peter Vavassis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Vavassis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Vavassis. The network helps show where Peter Vavassis may publish in the future.

Co-authorship network of co-authors of Peter Vavassis

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Vavassis. A scholar is included among the top collaborators of Peter Vavassis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Vavassis. Peter Vavassis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nabid, Abdenour, Nathalie Carrier, André‐Guy Martin, et al.. (2025). Impact of testosterone recovery after androgen deprivation therapy on overall survival in patients with high-risk prostate cancer: Long-term data from a phase III trial.. Journal of Clinical Oncology. 43(5_suppl). 310–310.
2.
Hijal, Tarek, Peter Vavassis, Marie‐Christine Guilbert, et al.. (2024). Single preoperative radiation therapy with delayed surgery for low-risk breast cancer: Oncologic outcome, toxicity and cosmesis of the SPORT-DS phase I trial. Radiotherapy and Oncology. 200. 110515–110515. 2 indexed citations
3.
Nabid, Abdenour, Nathalie Carrier, André‐Guy Martin, et al.. (2024). Quality of life and testosterone recovery after androgen deprivation therapy in high-risk prostate cancer patients: long-term data from a phase III trial. Quality of Life Research. 34(3). 725–737.
4.
Sidéris, Lucas, et al.. (2024). Concurrent Olaparib and Radiation Therapy for BRCA2-Mutated Breast Cancer. Advances in Radiation Oncology. 9(7). 101528–101528. 2 indexed citations
5.
Nabid, Abdenour, Nathalie Carrier, Éric Vigneault, et al.. (2024). Testosterone recovery after androgen deprivation therapy in localised prostate cancer: Long-term data from two randomised trials. Radiotherapy and Oncology. 195. 110256–110256. 5 indexed citations
6.
Nabid, Abdenour, Nathalie Carrier, André‐Guy Martin, et al.. (2023). Quality of life comparison based on testosterone recovery after androgen deprivation therapy in patients cured from high-risk prostate cancer: Long term data from a phase III trial.. JCO Oncology Practice. 19(11_suppl). 333–333. 1 indexed citations
7.
Nabid, Abdenour, Nathalie Carrier, André‐Guy Martin, et al.. (2023). Testosterone recovery in patients with prostate cancer treated with radiotherapy and different ADT duration: Long-term data from two randomized trials.. Journal of Clinical Oncology. 41(6_suppl). 300–300. 6 indexed citations
8.
Nabid, Abdenour, Nathalie Carrier, Éric Vigneault, et al.. (2021). Optimizing Treatment in Intermediate-Risk Prostate Cancer: Secondary Analysis of a Randomized Phase 3 Trial. International Journal of Radiation Oncology*Biology*Physics. 111(3). 732–740. 6 indexed citations
9.
Vavassis, Peter, David H. Nguyen, Marie‐Christine Guilbert, et al.. (2020). Tumour Response 3 Months after Neoadjuvant Single-Fraction Radiotherapy for Low-Risk Breast Cancer. Current Oncology. 27(3). 155–158. 8 indexed citations
10.
Nabid, Abdenour, Nathalie Carrier, Éric Vigneault, et al.. (2020). Androgen deprivation therapy and radiotherapy in intermediate-risk prostate cancer: A randomised phase III trial. European Journal of Cancer. 143. 64–74. 27 indexed citations
11.
Vavassis, Peter, David H. Nguyen, B. Fortin, et al.. (2020). Abstract P4-12-07: Single pre-operative radiation therapy (SPORT) trial for low risk breast cancer: A phase 1 study comparing pathological findings in immediate versus delayed surgery. Cancer Research. 80(4_Supplement). P4–12. 1 indexed citations
12.
Vavassis, Peter, et al.. (2017). Hypofractionation for prostate cancer: an update. Expert Review of Endocrinology & Metabolism. 12(3). 199–205. 1 indexed citations
13.
14.
Gulybán, Ákos, Nicolas Jansen, Laurence Seidel, et al.. (2015). Respiratory Motion, Anterior Heart Displacement and Heart Dosimetry: Comparison Between Prone (Pr) and Supine (Su) Whole Breast Irradiation. Pathology & Oncology Research. 21(4). 1051–1058. 13 indexed citations
15.
Gulybán, Ákos, et al.. (2015). The Influence of Treatment Position (Prone vs. Supine) on Clip Displacement, Seroma, Tumor Bed and Partial Breast Target Volumes: Comparative Study. Pathology & Oncology Research. 22(3). 493–500. 8 indexed citations
16.
Yassa, Michael, et al.. (2014). Fiducial marker implantation in prostate radiation therapy: Complication rates and technique. Cancer/Radiothérapie. 18(8). 736–739. 24 indexed citations
17.
Hathout, Lara, Tarek Hijal, Valérie Théberge, et al.. (2013). Hypofractionated Radiation Therapy for Breast Ductal Carcinoma In Situ. International Journal of Radiation Oncology*Biology*Physics. 87(5). 1058–1063. 29 indexed citations
18.
Vavassis, Peter, David H. Nguyen, Jean-Paul Bahary, & Michael Yassa. (2012). Hypofractionated radiotherapy in prostate cancer. Expert Review of Anticancer Therapy. 12(7). 965–972. 3 indexed citations
19.
Vavassis, Peter, et al.. (2009). Tumor Margin after conservative breast cancer surgery for early disease: an issue or not ?. Open Repository and Bibliography (University of Liège). 3(3).
20.
Vavassis, Peter, et al.. (2008). Phase 2 study of silver leaf dressing for treatment of radiation-induced dermatitis in patients receiving radiotherapy to the head and neck.. PubMed. 37(1). 124–9. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by O. Hernando Breakdown of academic impact, for papers by Mariacarla Valli Breakdown of academic impact, for papers by Fabio Arcidiacono Breakdown of academic impact, for papers by Davide Giovanni Bosetti Breakdown of academic impact, for papers by Feisal Bunkheila Breakdown of academic impact, for papers by Mark Churn Breakdown of academic impact, for papers by S. Voruganti Breakdown of academic impact, for papers by Archi Agarwal Breakdown of academic impact, for papers by K. Peignaux-Casasnovas Breakdown of academic impact, for papers by Mukesh B. Mukesh
Rankless by CCL
2026